NasdaqGM:AUPHBiotechs
A Look At Aurinia Pharmaceuticals (AUPH) Valuation After Its Recent Leadership Overhaul
Leadership overhaul and fresh management lineup at Aurinia
Aurinia Pharmaceuticals (AUPH) has undergone a broad leadership reset, with Kevin Tang becoming Chief Executive Officer, Michael Hearne stepping in as Chief Financial Officer, and Ryan Cole taking on the Chief Operating Officer role.
These appointments follow the departure of former CEO Peter Greenleaf and several senior officers. They also bring in multiple executives with ties to Tang Capital Management, a shift that many investors...